Pre-launch · MDL applied with Health Canada

Rapid answers.
Immediate confidence.

ImmediKits is bringing a focused portfolio of Class II, III and IV rapid diagnostic test kits to Canada and the wider North American market — fast, reliable point-of-care testing for clinics, pharmacies, hospitals and public-health programs.

Medical Device Licence applications are in process. Products are not yet available for sale.

One focus: rapid testing

A portfolio built across three Health Canada device classes
II
Class II

Pregnancy, fertility and drug-screening tests

III
Class III

Respiratory, strep, cardiac, oncology-marker and STI tests

IV
Class IV

HIV and hepatitis B / C screening tests

Introducing ImmediKits

Rapid diagnostics, brought to North America the right way.

ImmediKits is a new rapid-diagnostics brand entering the Canadian and North American market with a single, clear focus: point-of-care rapid test kits. We work with established international manufacturers to bring proven test formats — cassettes, strips, panels and combo tests — to the healthcare providers who need answers in minutes, not days.

We are building licence-first. Our Medical Device Licence (MDL) applications have been submitted to Health Canada, and every kit on this site will remain “coming soon” until it is licensed. In the meantime we are building our distributor network across Canada and North America so that partners are ready on launch day.

Our name says it: Immediate results, from Kits that are simple to run, easy to stock and backed by transparent documentation.

3
Device classes — II, III and IV
13+
Rapid test kits in the launch pipeline
<20 min
Typical time to result
MDL
Applications submitted to Health Canada
Why ImmediKits

Built for point-of-care, built for partners

Results in minutes

Rapid formats that deliver results at the point of care, typically in 5–20 minutes.

Licence-first

MDL applications submitted. We sell nothing in Canada until each kit is licensed.

Focused portfolio

Only rapid test kits — across infectious disease, cardiac, endocrine, toxicology and more.

North American reach

Launching in Canada with a distributor network planned across North America.

Device classes

A portfolio across Class II, III and IV

Health Canada classifies in-vitro diagnostic devices by risk. ImmediKits covers the full range used in rapid point-of-care testing.

II

Class II — lower risk

Everyday screening tests used in clinics, pharmacies and at home.

  • hCG pregnancy
  • Multi-drug panels
  • Ovulation (LH)
View Class II
III

Class III — moderate-high risk

Tests that guide time-sensitive clinical decisions.

  • COVID-19, Influenza A/B & combo
  • Strep A
  • Cardiac troponin I
  • Oncology markers & syphilis
View Class III
IV

Class IV — highest risk

Screening for serious blood-borne infections.

  • HIV 1/2
  • Hepatitis B (HBsAg)
  • Hepatitis C (HCV)
View Class IV

Classes shown are anticipated and subject to Health Canada’s determination.

Launch pipeline

Featured rapid test kits

A preview of the kits in our MDL pipeline. All listings are “coming soon” and are not available for sale.

CLASS IIIMDL applied
Respiratory

COVID-19 Antigen Rapid Test

Rapid detection of SARS-CoV-2 antigen to support point-of-care screening.

Target
SARS-CoV-2 nucleocapsid antigen
Specimen
Nasal / nasopharyngeal swab
Result in
15 min
Setting
Point-of-care, clinics, workplaces
Coming soonView details
CLASS IIIMDL applied
Throat · Bacterial

Strep A Rapid Test

Rapid detection of Group A strep antigen to support pharyngitis assessment.

Target
Group A Streptococcus antigen
Specimen
Throat swab
Result in
5–10 min
Setting
Clinics, pharmacy, paediatrics
Coming soonView details
CLASS IIIMDL applied
Cardiac

Cardiac Troponin I Rapid Test

Qualitative detection of cardiac troponin I to support rapid cardiac assessment.

Target
cTnI · Whole blood / serum / plasma
Specimen
Whole blood, serum, plasma
Result in
10–15 min
Setting
Emergency, clinics, ambulatory care
Coming soonView details
CLASS IVMDL applied
Infectious disease

HIV 1/2 Rapid Test

Rapid detection of antibodies to HIV-1 and HIV-2 for point-of-care screening.

Target
HIV-1 / HIV-2 antibody
Specimen
Fingerstick whole blood, serum, plasma
Result in
15 min
Setting
Clinics, public health, outreach
Coming soonView details
CLASS IIMDL applied
Reproductive health

hCG Pregnancy Rapid Test

Qualitative detection of hCG for early confirmation of pregnancy.

Target
Human chorionic gonadotropin · Cassette / strip
Specimen
Urine
Result in
3–5 min
Setting
Clinic, pharmacy, home use
Coming soonView details
CLASS IIMDL applied
Toxicology

Multi-Drug Panel Rapid Test

Screens for multiple drug classes at once, in configurable 5- to 12-panel formats.

Target
Drugs of abuse · Multi-panel cup / dip card
Specimen
Urine
Result in
5 min
Setting
Clinics, workplace, treatment programs
Coming soonView details
Distributor program

How partnering with ImmediKits works

Apply

Tell us about your company, territory and the customers you serve.

Review

We review fit, coverage and capabilities, then schedule an introductory call.

Prepare

Receive product documentation and plan launch volumes for your territory.

Launch

Begin supplying as each kit’s Medical Device Licence is issued.

Become an ImmediKits distributor

We are building our distribution network across Canada and North America ahead of launch. Medical distributors, pharmacy wholesalers, lab suppliers and group purchasing partners are invited to apply.

Apply to distribute →
Regulatory notice. ImmediKits has applied to Health Canada for Medical Device Licences (MDL) for the rapid test kits shown on this site. Licences have not yet been issued. Products are not currently available for sale in Canada, and nothing on this website is an offer of sale. Device classes shown are anticipated classifications and are subject to Health Canada’s determination. No claim of Health Canada approval, clinical performance or efficacy is made. Product details are provided for information and distributor planning only.